Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

03 November, 2026 | Tuesday

Sesen Bio and Carisma Therapeutics Announce Substantial Increase to Expected Special Cash Dividend in Connection with Pending Merger

Sesen Bio Stockholders Expected to Receive Approximately $70 Million Special Cash Dividend, an Increase from up to $25 Million Previously Announced Cont...

January 02, 2023 | Monday | News

Vaxart Secures European Patent Protection for Oral Norovirus Vaccine Technology

Vaxart, Inc., a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform, an...

August 28, 2026 | Friday | News

Partner Content

Vetter Pharma Expands Fill-Finish Capacity to Meet Growing Demand for Injectable Medicines
15 October, 2026
DaltonTx on Building a More Evidence-Led Approach to Antibody Discovery
14 October, 2026
Grünenthal on Expanding Pain Treatment Access Across Asia-Pacific
13 October, 2026
AtomVie Opens $160 Million Radiopharmaceutical Manufacturing Facility in Ontario
07 September, 2026
Resonant Clinical Solutions Acquires Creapharm Bioservices to Expand European Biorepository Capabilities
07 September, 2026
EB Development Plans Public Withdrawal Offer for Eurobio Scientific at €25.30 Per Share
18 September, 2026

BioPharma BreakThrough's

Curaleaf and Jupiter Research Launch QMID Medical Cannabis Inhalation Device in Australia
05 October, 2026
Samfara Acquires Chr. Olesen Synthesis to Expand Pharmaceutical API Business
05 October, 2026
Replimune Launches TUDRIQEV in US for Advanced Melanoma Following FDA Approval
05 October, 2026
Axogen Completes BioCircuit Acquisition to Expand Peripheral Nerve Repair Portfolio
05 October, 2026
Everest Medicines Advances Local Manufacturing of VELSIPITY in China with Priority Review
05 October, 2026
DaltonTx Launches Advanced Antibody Discovery Capabilities for AI-Driven Drug Development
02 October, 2026

Editor Picks

Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development
30 September, 2026
Caspian Therapeutics Reports KO-7246 Data in Type 1 and Type 2 Diabetes
30 September, 2026
Kither Biotech Doses First Patients in KIT2014 COPD Clinical Trial
30 September, 2026
Vetter Expands Global Fill-and-Finish Network with Ten New Manufacturing Lines
29 September, 2026
Codexis Partners with siRNA Innovator to Advance Enzymatic Oligonucleotide Manufacturing
30 September, 2026
Tandem Diabetes Care Expands Tandem Mobi Automated Insulin Delivery to 12 Global Markets
29 September, 2026
QIAGEN Expands US QIAstat-Dx Bloodstream Infection Testing with New FDA-Cleared Panel
29 September, 2026

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2026 Biopharma Boardroom. All Rights Reserved.